David Lowrance
Patrimonio netto: 3 M $ in data 31/08/2026
Patrimonio netto: 3 M $ in data 31/08/2026
David L.
Lowrance is currently the Director at Life Science Washington since 2014 and Secretary at Savara, Inc. since 2016.
Formerly, Mr. Lowrance was Chief Financial Officer & Treasurer at Edgemont Pharmaceuticals LLC from 2014 to 2016, Chief Financial Officer & Secretary at Acucela, Inc. from 2011 to 2014, Chief Financial Officer & Vice President at Cumberland Pharmaceuticals, Inc. from 2003 to 2011, Head-Finance at BorgWarner, Inc., Senior Accountant at Ernst & Young LLP, Chief Financial Officer at Aravas, Inc., and Chief Financial Officer at Kubota Pharmaceutical Holdings Co., Ltd. Education includes an undergraduate degree from the University of Georgia, conferred in 1989.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SAVARA, INC. 0,26% | 22/06/2026 | 536.032 ( 0,26% ) | 3 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SAVARA INC. | Segretario Aziendale | 01/07/2017 |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Direttore/Membro del Consiglio | 01/07/2014 |
| Società | Posizione | Fine |
|---|---|---|
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Direttore Finanziario/CFO | 01/10/2016 |
| ACUCELA INC | Direttore Finanziario/CFO | 19/09/2014 |
| CUMBERLAND PHARMACEUTICALS INC. | Direttore Finanziario/CFO | 04/04/2011 |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative drugs for the treatment of serious and life-threatening conditions | Direttore Finanziario/CFO | - |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
BorgWarner, Inc.
BorgWarner, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures combustion, hybrid and electric technologies for light, medium and heavy duty vehicles | Producer Manufacturing |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Cumberland Pharmaceuticals, Inc.
Cumberland Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, develops and commercializes branded prescription products | Health Technology |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative drugs for the treatment of serious and life-threatening conditions | Health Technology |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Kubota Pharmaceutical Holdings Co. Ltd.
Kubota Pharmaceutical Holdings Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines and medical devices for eye diseases | Health Technology |
Savara, Inc.
Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale